An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.
Since the 1970s, the spread of multidrug-resistant (MDR) Acinetobacter strains among critically ill, hospitalized patients, and subsequent epidemics, have become an increasing cause of concern. Reports of community-acquired Acinetobacter infections have also increased over the past decade. A recent manifestation of MDR Acinetobacter that has attracted public attention is its association with infections in severely injured soldiers. Here, we present an overview of the current knowledge of the genus Acinetobacter, with the emphasis on the clinically most important species, Acinetobacter baumannii.
Dijkshoorn
Lenie
L
Department of Infectious Diseases C5-P, Leiden University Medical Centre, Albinusdreef 2, P.O. BOX 9600, 2300 RC Leiden, The Netherlands. l.dijkshoorn@lumc.nl
Nemec
Alexandr
A
Seifert
Harald
H
D000151:Acinetobacter Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D040981:Acinetobacter baumannii / Q000187:drug effects* / Q000235:genetics / Q000254:growth & development / Q000502:physiology*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D003428:Cross Infection / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D008826:Microbial Sensitivity Tests; D015995:Prevalence
D000900:Anti-Bacterial Agents